Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Reduced bone length, growth plate thickness, bone content, and IGF-I as a model for poor growth in the CFTR-deficient rat.

Stalvey MS, Havasi V, Tuggle KL, Wang D, Birket S, Rowe SM, Sorscher EJ.

PLoS One. 2017 Nov 30;12(11):e0188497. doi: 10.1371/journal.pone.0188497. eCollection 2017.

2.

Growth in Prepubertal Children With Cystic Fibrosis Treated With Ivacaftor.

Stalvey MS, Pace J, Niknian M, Higgins MN, Tarn V, Davis J, Heltshe SL, Rowe SM.

Pediatrics. 2017 Feb;139(2). pii: e20162522. doi: 10.1542/peds.2016-2522.

3.

Cystic fibrosis-related bone disease: insights into a growing problem.

Stalvey MS, Clines GA.

Curr Opin Endocrinol Diabetes Obes. 2013 Dec;20(6):547-52. doi: 10.1097/01.med.0000436191.87727.ec. Review.

4.

Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease.

Stalvey MS, Clines KL, Havasi V, McKibbin CR, Dunn LK, Chung WJ, Clines GA.

PLoS One. 2013 Nov 13;8(11):e80098. doi: 10.1371/journal.pone.0080098. eCollection 2013.

5.

A multi-center controlled trial of growth hormone treatment in children with cystic fibrosis.

Stalvey MS, Anbar RD, Konstan MW, Jacobs JR, Bakker B, Lippe B, Geller DE.

Pediatr Pulmonol. 2012 Mar;47(3):252-63. doi: 10.1002/ppul.21546. Epub 2011 Sep 8.

6.

Endocrine parameters of cystic fibrosis: back to basics.

Stalvey MS, Flotte TR.

J Cell Biochem. 2009 Oct 1;108(2):353-61. doi: 10.1002/jcb.22284. Review.

PMID:
19670266
7.

Murine model for cystic fibrosis bone disease demonstrates osteopenia and sex-related differences in bone formation.

Pashuck TD, Franz SE, Altman MK, Wasserfall CH, Atkinson MA, Wronski TJ, Flotte TR, Stalvey MS.

Pediatr Res. 2009 Mar;65(3):311-6. doi: 10.1203/PDR.0b013e3181961e80.

8.

Growth hormone therapy improves growth in children with cystic fibrosis related liver disease.

Stalvey MS, Torrez DM, Hillan J, Gonzalez-Peralta RP, Haafiz A, Rosenbloom AL.

J Pediatr Endocrinol Metab. 2008 Aug;21(8):793-7.

PMID:
18825880
9.

CFTR mutations impart elevated immune reactivity in a murine model of cystic fibrosis related diabetes.

Stalvey MS, Brusko TM, Mueller C, Wasserfall CH, Schatz DA, Atkinson MA, Flotte TR.

Cytokine. 2008 Oct;44(1):154-9. doi: 10.1016/j.cyto.2008.07.468. Epub 2008 Sep 7.

PMID:
18778952
10.

Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury.

Stalvey MS, Muller C, Schatz DA, Wasserfall CH, Campbell-Thompson ML, Theriaque DW, Flotte TR, Atkinson MA.

Diabetes. 2006 Jul;55(7):1939-45.

11.

Predictors of control of diabetes: monitoring may be the key.

Haller MJ, Stalvey MS, Silverstein JH.

J Pediatr. 2004 May;144(5):660-1.

PMID:
15127007

Supplemental Content

Loading ...
Support Center